Related Experiment Video
Updated: Aug 28, 2025
07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.5K
Alanine-Serine-Cysteine Transporter 2 Inhibition Suppresses Prostate Cancer Cell Growth In Vitro
Masanobu Saruta1, Kiyoshi Takahara1, Atsuhiko Yoshizawa1
1Department of Urology, Fujita-Health University School of Medicine, Nagoya 470-1192, Japan.
Journal of Clinical Medicine
|September 23, 2022
Summary
Alanine-serine-cysteine transporter 2 (ASCT2) inhibition significantly reduced prostate cancer cell proliferation. This finding holds promise for treating both castration-sensitive and castration-resistant prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Alanine-serine-cysteine transporter 2 (ASCT2) is linked to heightened metabolism in cancers.
- ASCT2's specific role in prostate cancer (PCa) cell proliferation requires further elucidation.
Purpose of the Study:
- To investigate the impact of ASCT2 expression on prostate cancer patient outcomes.
- To evaluate ASCT2's function in both castration-sensitive PCa (CSPC) and castration-resistant PCa (CRPC) cell lines.
Main Methods:
- Utilized the cBioPortal database for patient outcome analysis (108 PCa patients).
- Employed cell proliferation assays and Western blot analyses on LNCaP and 22Rv1 cell lines.
- ASCT2 function was assessed via siRNA inhibition in vitro.
Main Results:
- ASCT2 expression correlated with biochemical recurrence-free survival in PCa patients with Gleason score ≥ 7.
- Combined ASCT2 siRNA and enzalutamide therapy significantly reduced LNCaP cell growth.
- ASCT2 inhibition suppressed 22Rv1 cell growth by downregulating ARV7 under various conditions.
Conclusions:
- ASCT2 inhibition effectively reduces proliferation in both CSPC and CRPC cells in vitro.
- ASCT2 represents a potential therapeutic target for prostate cancer treatment.
Related Concept Videos
01:19Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.8K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K